2021 No. 222

Dangerous Drugs

F1The Misuse of Drugs (Designation) (Amendment) Regulations (Northern Ireland) 2021

Made

Coming into operation

The Department of Health makes the following Regulations in exercise of the powers conferred by section 7(4) and (5) of the Misuse of Drugs Act 1971 as adapted by section 7(9) of that Act and now vested in it and after consultation with the Advisory Council on the Misuse of Drugs in accordance with section 7(7) of that Act.

Annotations:

Citation, commencement and interpretation1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Amendment of the Misuse of Drugs Regulations (Northern Ireland) 20022

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Sealed with the Official Seal of the Department of Health on 28th July 2021

(L.S.)Cathy HarrisonA senior officer of the Department of Health
EXPLANATORY NOTE

(This note is not part of the Order)

This Order amends the Misuse of Drugs (Designation) Order (Northern Ireland) 2001 (S.R. 2001 No. 431) (“the Order”).

Section 7(3) of the Misuse of Drugs Act 1971 (c. 38) (“the 1971 Act”) requires regulations to be made to allow the use for certain purposes, including medical use, of the drugs which are subject to control under that Act. Section 7(4)(b) of the 1971 Act provides, however, that designated controlled drugs will be exempt from this easement and so cannot lawfully be prescribed, administered, produced, compounded or supplied except under licence or other authority issued by the Department of Health. The designations in question are in the Misuse of Drugs (Designation) Order (Northern Ireland) 2001 (“the Order”). Part 1 of Schedule 1 to the Order is amended by adding flualprazolam, flunitrazolam and norfludiazepam to that Part (which specifies controlled drugs to which section 7(4) of the 1971 Act applies).